December 2019
Washington D.C. (Dec. 9, 2019)—Today, Rep. Jerrold Nadler (D-NY), the Chairman of the Judiciary Committee, and Rep. Carolyn Maloney (D-NY), the Chairwoman of the Committee on Oversight and Reform, issued the following joint statement on the Department of Justice (DOJ) Inspector General (IG) Report on the origins of the Russia investigation:
Washington D.C. (Dec. 9, 2019)—On Tuesday, December 10, 2019, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, will hold a hearing assessing scientific methods utilized to detect asbestos in talcum powders, and public health ramifications.
Washington D.C. (Dec. 9, 2019)—On Tuesday, December 10, 2019, Chairwoman Carolyn B. Maloney will hold a hearing on the need for comprehensive national paid family and medical leave in the United States and policies to improve access across the country.
WHERE: 2154 Rayburn House Office Building
WHEN: Tuesday, December 10, 2019
TIME: 10:00 a.m. EST
Washington, D.C. (Dec. 5, 2019)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter to the Food and Drug Administration (FDA) pressing them to expeditiously release the results of additional tests it conducted after initially finding asbestos in Johnson & Johnson's talc-based baby powder.
Washington, D.C. (Dec. 5, 2019)—Rep.
Washington, DC – Today, the House Permanent Select Committee on Intelligence released the draft report – "The Trump-Ukraine Impeachment Inquiry Report" – to all Members and the public. The Committee will vote tonight to issue the report, before the Chairman of the Committee transmits it and any accompanying materials to the House Judiciary Committee consistent with H.Res. 660.
The draft report was written by the staff of the House Intelligence, Oversight and Reform and Foreign Affairs Committees.
Washington D.C. (Dec. 3, 2019)—On Wednesday, December 4, 2019, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, will hold a hearing about the federal response to the epidemic of e-cigarette use, especially among children, and the Food and Drug Administration's (FDA) compliance policy.
WHERE: 2154 Rayburn House Office Building